Suninflam Inc

1 clinical trials · Sponsor

Record	Firm	Date
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients (NCT07051629)	Suninflam Inc	2025-06-16

Every clearance here is in the API, with alerts when new ones post.